| Record Information |
|---|
| Version | 1.0 |
|---|
| Creation Date | 2016-07-13 19:42:24 UTC |
|---|
| Update Date | 2020-03-19 21:19:42 UTC |
|---|
| Lmdb | LMDB00102 |
|---|
| Secondary Accession Numbers | None |
|---|
| Metabolite Identification |
|---|
| Common Name | L-Palmitoylcarnitine |
|---|
| Description | L-Palmitoylcarnitine is a long-chain acyl fatty acid derivative ester of carnitine which facilitates the transfer of long-chain fatty acids from cytoplasm into mitochondria during the oxidation of fatty acids. L-palmitoylcarnitine, due to its amphipatic character is, like detergents, a surface-active molecule and by changing the membrane fluidity and surface charge can change activity of several enzymes and transporters localized in the membrane. L-palmitoylcarnitine has been also reported to change the activity of certain proteins. On the contrary to carnitine, palmitoylcarnitine was shown to stimulate the activity of caspases 3, 7 and 8 and the level of this long-chain acylcarnitine increased during apoptosis. Palmitoylcarnitine was also reported to diminish completely binding of phorbol esters, the protein kinase C activators and to decrease the autophosphorylation of the enzyme. Apart from these isoform nonspecific phenomena, palmitoylcarnitine was also shown to be responsible for retardation in cytoplasm of protein kinase C isoforms β and δ and, in the case of the latter one, to decrease its interaction with GAP-43. Some of the physico-chemical properties of palmitoylcarnitine may help to explain the need for coenzyme A-carnitine-coenzyme A acyl exchange during mitochondrial fatty acid import. The amphiphilic character of palmitoylcarnitine may also explain its proposed involvement in the pathogenesis of myocardial ischemia. L-Palmitoylcarnitine accumulates in ischemic myocardium and potentially contribute to myocardial damage through alterations in membrane molecular dynamics , one mechanism through which could play an important role in ischemic injury. Palmitoylcarnitine is characteristically elevated in carnitine palmitoyltransferase II deficiency, late-onset (OMIM 255110 ). (PMID 2540838 , 15363641 , 8706815 ). |
|---|
| Structure | |
|---|
| Synonyms | | Value | Source |
|---|
| (3R)-3-(Hexadecanoyloxy)-4-(trimethylazaniumyl)butanoate | ChEBI | | (3R)-3-Palmitoyloxy-4-(trimethylammonio)butanoate | ChEBI | | Hexadecanoyl-L-carnitine | ChEBI | | Hexadecanoylcarnitine | ChEBI | | Hexadecenoyl carnitine | ChEBI | | L-Carnitine palmitoyl ester | ChEBI | | O-Hexadecanoyl-(R)-carnitine | ChEBI | | O-Hexadecanoyl-R-carnitine | ChEBI | | Palmitoyl-L-carnitine | ChEBI | | Palmitoylcarnitine | ChEBI | | (3R)-3-(Hexadecanoyloxy)-4-(trimethylazaniumyl)butanoic acid | Generator | | (3R)-3-Palmitoyloxy-4-(trimethylammonio)butanoic acid | Generator | | (+)-Palmitoylcarnitine | HMDB | | 3-Carboxy-N,N,N-trimethyl-2-[(1-oxohexadecyl)oxy]-1-propanaminium | HMDB | | L(-)-Palmitylcarnitine | HMDB | | L-Palmitoyl-L-carnitine | HMDB | | Palmitoyl-(-)-carnitine | HMDB | | Palmityl-L-carnitine | HMDB | | Palmitylcarnitine | HMDB | | (2R)-Palmitoylcarnitine | HMDB | | C16 Carnitine | HMDB | | L-Palmitoylcarnitine | HMDB |
|
|---|
| Chemical Formula | C23H45NO4 |
|---|
| Average Molecular Weight | 399.6077 |
|---|
| Monoisotopic Molecular Weight | 399.334858933 |
|---|
| IUPAC Name | (3R)-3-(hexadecanoyloxy)-4-(trimethylazaniumyl)butanoate |
|---|
| Traditional Name | palmitoylcarnitine |
|---|
| CAS Registry Number | 2364-67-2 |
|---|
| SMILES | CCCCCCCCCCCCCCCC(=O)O[C@H](CC([O-])=O)C[N+](C)(C)C |
|---|
| InChI Identifier | InChI=1S/C23H45NO4/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-23(27)28-21(19-22(25)26)20-24(2,3)4/h21H,5-20H2,1-4H3/t21-/m1/s1 |
|---|
| InChI Key | XOMRRQXKHMYMOC-OAQYLSRUSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | belongs to the class of organic compounds known as acyl carnitines. These are organic compounds containing a fatty acid with the carboxylic acid attached to carnitine through an ester bond. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Lipids and lipid-like molecules |
|---|
| Class | Fatty Acyls |
|---|
| Sub Class | Fatty acid esters |
|---|
| Direct Parent | Acyl carnitines |
|---|
| Alternative Parents | |
|---|
| Substituents | - Acyl-carnitine
- Dicarboxylic acid or derivatives
- Tetraalkylammonium salt
- Quaternary ammonium salt
- Carboxylic acid ester
- Carboxylic acid salt
- Carboxylic acid derivative
- Carboxylic acid
- Organic nitrogen compound
- Organooxygen compound
- Organonitrogen compound
- Organic salt
- Hydrocarbon derivative
- Organic oxide
- Organopnictogen compound
- Organic oxygen compound
- Carbonyl group
- Amine
- Aliphatic acyclic compound
|
|---|
| Molecular Framework | Aliphatic acyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Status | Detected and Quantified |
|---|
| Origin | Not Available |
|---|
| Biofunction | Not Available |
|---|
| Application | Not Available |
|---|
| Cellular locations | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Predicted Properties | |
|---|
| Spectra |
|---|
| Spectra | | Spectrum Type | Description | Splash Key | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, Positive | splash10-00di-9220000000-890219021b84f6894540 | Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, Positive | Not Available | Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, Positive | Not Available | Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (TMS_1_1) - 70eV, Positive | Not Available | Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | Spectrum | | LC-MS/MS | LC-MS/MS Spectrum - Quattro_QQQ 10V, Positive (Annotated) | splash10-0udi-1000900000-109f35c9819eb5eed7b7 | Spectrum | | LC-MS/MS | LC-MS/MS Spectrum - Quattro_QQQ 25V, Positive (Annotated) | splash10-000i-9000000000-9d6bb14eddb4cfa8341a | Spectrum | | LC-MS/MS | LC-MS/MS Spectrum - Quattro_QQQ 40V, Positive (Annotated) | splash10-000i-9000000000-87b1d0debe4e0cb7bd31 | Spectrum | | LC-MS/MS | LC-MS/MS Spectrum - Linear Ion Trap , negative | splash10-014i-0139500000-21c36c851939b94d4523 | Spectrum | | LC-MS/MS | LC-MS/MS Spectrum - Linear Ion Trap , negative | splash10-014i-0029600000-69ebe292c2ce42c8d810 | Spectrum | | LC-MS/MS | LC-MS/MS Spectrum - Linear Ion Trap , positive | splash10-0f6x-0139600000-197944fd1aa4ac44bdd2 | Spectrum | | LC-MS/MS | LC-MS/MS Spectrum - Linear Ion Trap , positive | splash10-0uxr-0000613900-006582b143e5906e51cc | Spectrum | | LC-MS/MS | LC-MS/MS Spectrum - Linear Ion Trap , positive | splash10-0uxr-0000614900-14a5d773f652b71671fb | Spectrum | | LC-MS/MS | LC-MS/MS Spectrum - Linear Ion Trap , positive | splash10-0f6x-0139600000-b0528be9c13e412551af | Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-0udi-0000900000-b54b0a7f2164f15f15f2 | Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-0f79-9000500000-d7434e08a3e0942fa2e9 | Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-000i-9000000000-e9262cbaff8cb4ad0ba6 | Spectrum | | 1D NMR | 1H NMR Spectrum | Not Available | Spectrum | | 1D NMR | 13C NMR Spectrum | Not Available | Spectrum | | 1D NMR | 1H NMR Spectrum | Not Available | Spectrum | | 1D NMR | 13C NMR Spectrum | Not Available | Spectrum | | 1D NMR | 1H NMR Spectrum | Not Available | Spectrum | | 1D NMR | 13C NMR Spectrum | Not Available | Spectrum | | 1D NMR | 1H NMR Spectrum | Not Available | Spectrum | | 1D NMR | 13C NMR Spectrum | Not Available | Spectrum | | 1D NMR | 1H NMR Spectrum | Not Available | Spectrum | | 1D NMR | 13C NMR Spectrum | Not Available | Spectrum | | 1D NMR | 1H NMR Spectrum | Not Available | Spectrum | | 1D NMR | 13C NMR Spectrum | Not Available | Spectrum | | 1D NMR | 1H NMR Spectrum | Not Available | Spectrum | | 1D NMR | 13C NMR Spectrum | Not Available | Spectrum | | 1D NMR | 1H NMR Spectrum | Not Available | Spectrum | | 1D NMR | 13C NMR Spectrum | Not Available | Spectrum | | 1D NMR | 1H NMR Spectrum | Not Available | Spectrum | | 1D NMR | 13C NMR Spectrum | Not Available | Spectrum | | 1D NMR | 1H NMR Spectrum | Not Available | Spectrum | | 1D NMR | 13C NMR Spectrum | Not Available | Spectrum | | 1D NMR | 1H NMR Spectrum | Not Available | Spectrum | | 2D NMR | [1H,13C] 2D NMR Spectrum | Not Available | Spectrum |
|
|---|
| General References | - Watanabe H, Kobayashi A, Hayashi H, Yamazaki N: Effects of long-chain acyl carnitine on membrane fluidity of human erythrocytes. Biochim Biophys Acta. 1989 Apr 28;980(3):315-8. [2540838 ]
- Nalecz KA, Miecz D, Berezowski V, Cecchelli R: Carnitine: transport and physiological functions in the brain. Mol Aspects Med. 2004 Oct-Dec;25(5-6):551-67. [15363641 ]
- Goni FM, Requero MA, Alonso A: Palmitoylcarnitine, a surface-active metabolite. FEBS Lett. 1996 Jul 15;390(1):1-5. [8706815 ]
|
|---|